Results

RDF/XMLNTriplesTurtleShow queryShare
SubjectPredicateObject
http://purl.uniprot.org/citations/38127951http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/38127951http://www.w3.org/2000/01/rdf-schema#comment"

Background

Nonalcoholic fatty liver disease (NAFLD) is a complex disease which is characterized by the deposition of fats in the hepatocytes. Further, it progresses to nonalcoholic steatohepatitis (NASH), fibrosis, and hepatocellular carcinoma. The increasing prevalence of NAFLD urges to find the non-invasive predictive biomarkers. In this study, we sought to determine increased BMP8B levels as predictors for the progression of NAFLD.

Methods

In the present cross-sectional study, circulatory BMP8B levels were measured in healthy controls (n = 56), NAFL patients (n = 72) and NASH patients (n = 77) by using an ELISA kit. Human hepatic BMP8B mRNA expression was measured in the liver tissue of control and NASH patients. In addition, BMP8B expression was confirmed by immunohistochemistry analysis. Furthermore, hepatic BMP8B mRNA expression was measured in wild type (WT) mice, WT mice fed with choline deficient high fat diet (WT+CDHF), iNOS (inducible nitric oxide synthase) knockout (iNOS-/-) mice, iNOS-/-fed with CDHF diet (iNOS-/-+CDHF).

Results

Increased circulatory BMP8B levels and BMP8B mRNA expression in hepatic tissue were significantly higher in NASH patients as compared with the control subjects. BMP8B expression was increased parallel to the fibrosis score in the hepatic tissues of NASH patients. It was observed that increased BMP8B levels have shown a significant positive correlation between aspartate aminotransferase (r = 0.31, p = 0.005), alanine aminotransferase (r = 0.23, p = 0.045), APRI (r = 0.30, p = 0.009), and Fib-4 score (r = 0.25, p = 0.036) in NASH patients. BMP8B has maintained a significant association with NASH and shown high sensitivity (92.91%) and specificity (92.73%) in NASH patients. Furthermore, increased BMP8B mRNA expression levels were observed in iNOS-/-+CDHF mice.

Conclusion

Our study findings confirmed that BMP8B increases with the severity of the disease and BMP8B shows potential as a non-invasive predictive biomarker to identify NAFLD progression. However, future studies should investigate circulatory BMP8B levels in a large number of patients and also its impact on liver during NAFLD progression."xsd:string
http://purl.uniprot.org/citations/38127951http://purl.org/dc/terms/identifier"doi:10.1371/journal.pone.0295839"xsd:string
http://purl.uniprot.org/citations/38127951http://purl.uniprot.org/core/author"Kaur S."xsd:string
http://purl.uniprot.org/citations/38127951http://purl.uniprot.org/core/author"Yadav A."xsd:string
http://purl.uniprot.org/citations/38127951http://purl.uniprot.org/core/author"Banerjee S.K."xsd:string
http://purl.uniprot.org/citations/38127951http://purl.uniprot.org/core/author"Adela R."xsd:string
http://purl.uniprot.org/citations/38127951http://purl.uniprot.org/core/author"Kamboj P."xsd:string
http://purl.uniprot.org/citations/38127951http://purl.uniprot.org/core/author"Deka U.J."xsd:string
http://purl.uniprot.org/citations/38127951http://purl.uniprot.org/core/author"Mounika N."xsd:string
http://purl.uniprot.org/citations/38127951http://purl.uniprot.org/core/date"2023"xsd:gYear
http://purl.uniprot.org/citations/38127951http://purl.uniprot.org/core/name"PLoS One"xsd:string
http://purl.uniprot.org/citations/38127951http://purl.uniprot.org/core/pages"e0295839"xsd:string
http://purl.uniprot.org/citations/38127951http://purl.uniprot.org/core/title"Circulatory bone morphogenetic protein (BMP) 8B is a non-invasive predictive biomarker for the diagnosis of non-alcoholic steatohepatitis (NASH)."xsd:string
http://purl.uniprot.org/citations/38127951http://purl.uniprot.org/core/volume"18"xsd:string
http://purl.uniprot.org/citations/38127951http://www.w3.org/2004/02/skos/core#exactMatchhttp://purl.uniprot.org/pubmed/38127951
http://purl.uniprot.org/citations/38127951http://xmlns.com/foaf/0.1/primaryTopicOfhttps://pubmed.ncbi.nlm.nih.gov/38127951
http://purl.uniprot.org/uniprot/#_P34820-mappedCitation-38127951http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/38127951
http://purl.uniprot.org/uniprot/P34820http://purl.uniprot.org/core/mappedCitationhttp://purl.uniprot.org/citations/38127951